Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
‘We moeten ons voorbereiden op meer parasitaire infecties’
jun 2025 | Parasitaire infecties